Eric Choi, MD
Vascular Surgery · Philadelphia, PANPI 1306863865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $858 and has fallen 64.6% since, to $303 in 2025. That places this record below the midpoint for vascular surgery clinicians in PA, where the typical reported total is $3,795.
Across 19 payments — averaging $65.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$234
- Cook Medical LLC$198
- Medtronic$185
- Integra Lifesciences Corporation$164
- Abiomed$137
- Endologix LLC$109
- plus $209 from 6 others
Across 45 payments — averaging $1594.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$50K
- Humacyte Global, Inc.$14K
- Zimmer Biomet$8K
What the payments were for
- Food & beverage$1,237100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 2 | $234 |
| Cook Medical LLC | 2 | $198 |
| Medtronic | 4 | $185 |
| Integra Lifesciences Corporation | 1 | $164 |
| Abiomed | 1 | $137 |
| Endologix LLC | 2 | $109 |
| Haemonetics Corporation | 1 | $59 |
| Reapplix Inc. | 2 | $48 |
| Mindray DS USA, Inc. | 1 | $46 |
| BD | 1 | $23 |
| Inari Medical, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,237 in reported general payments places this provider in the 20th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Philadelphia
- Darren SchneiderPhiladelphia$569K
- Elizabeth GenovesePhiladelphia$343K
- Shang LohPhiladelphia$306K
- Edward WooPhiladelphia$58K
- Babak AbaiPhiladelphia$37K
- Ann GaffeyPhiladelphia$35K
- Venkat KalapatapuPhiladelphia$31K
- Roberto AruPhiladelphia$30K
- Alexander FairmanPhiladelphia$23K
- Nakul RaoPhiladelphia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.